LEPR and fatty liver disease: Conversely, blocking endogenous leptin signaling in the brain by infusing a leptin receptor antagonist (LpR antagonist; protocol in Fig. 1l) led to hepatic steatosis (Fig. 1m) without changes in body weight and food intake (Supplementary Figures 2g–i).